as on February 7, 2026 at 1:51 am IST
52 Week's Low
52 Week's High
15.62%
Downside
128.48%
Upside
Check Exozymes Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$98.3M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-940.69%
Compare market cap, revenue, PE, and other key metrics of Exozymes Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $98.3M | NA | NA | 0.00% | |
| BUY | $122.3B | 122.02% | 33.56 | 31.35% | |
| BUY | $47.7B | 98.75% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 57.42% | 18.28 | 32.13% |
Search interest for Exozymes Inc Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:100% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 58.4% return, outperforming this stock by 93.0%
Price Dip
![]()
In the last 3 months, EXOZ stock has moved down by -24.9%
| Organisation | Exozymes Inc |
| Headquarters | 750 Royal Oaks Drive, Monrovia, CA, United States, 91016 |
| CEO | Mr. Michael Heltzen |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Damien A. Perriman | Chief Commercial Officer |
Mr. Michael Heltzen | President & CEO |
Dr. Tyler Korman Ph.D. | Co-Founder & Vice President of Research |
Dr. Paul Opgenorth Ph.D. | Co-Founder & Vice President of Development |
Mr. Fouad Nawaz | Vice President of Finance |
Mr. James U. Bowie Ph.D. | Founder & Independent Director |
Mr. Lasse H. Gorlitz | Vice President of Communications |
Mr. Michael Burns | Executive Vice President of Energy Transition |
Dr. Zachary Karl Ph.D. | VP & Head of Business Development |
Exozymes Inc share price today is $10.5 as on at the close of the market. Exozymes Inc share today touched a day high of $10.5 and a low of $10.5.
Exozymes Inc share touched a 52 week high of $23.99 on and a 52 week low of $8.86 on . Exozymes Inc stock price today i.e. is closed at $10.5,which is 56.23% down from its 52 week high and 18.51% up from its 52 week low.
Exozymes Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Exozymes Inc (EXOZ) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Exozymes Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Exozymes Inc share’s latest price of $10.5 as on February 6, 2026 at 8:21 pm IST, you will get 0.9524 shares of Exozymes Inc. Learn more about
fractional shares .